Detection of mutated angiotensin I-converting enzyme by serum/plasma analysis using a pair of monoclonal antibodies

Clinical Chemistry

Volumn 51, Issue 6, 2005, Pages 1040-1043

  Danilov, Sergei M ^a   Deinum, Jaap ^b   Balyasnikova, Irina V ^a   Sun, Zhu Li ^a   Kramers, Cornelis ^b   Hollak, Carla E M ^c   Albrecht, Ronald F ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1B3; MONOCLONAL ANTIBODY 9B9; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANGIOTENSIN BLOOD LEVEL; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BLOOD ANALYSIS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME THERAPY; FEMALE; GAUCHER DISEASE; HUMAN; MALE; MUTATION; PHENOTYPE; PROTEIN BINDING; SARCOIDOSIS;

ADULT; ANTIBODIES, MONOCLONAL; GAUCHER DISEASE; HETEROZYGOTE; HUMANS; IMMUNOASSAY; MIDDLE AGED; MUTATION; PEPTIDYL-DIPEPTIDASE A; PLASMA; SARCOIDOSIS; SERUM;

EID: 19644373766     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.045633     Document Type: Article

References (32)

1. Ehlers MRW, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989;28:5311-8.
2. Corvol P, Williams TA, Soubrier F. Dipeptidyl dipeptidase: angiotensin-converting enzyme. Methods Enzymol 1995;248:283-305.
3. Dzau VJ, Bernstein K, Celermajer D, Cohen J, Dahlof B, Deanfield J, et al. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol 2001;88(Suppl):1L-20L
4. Franke FE, Metzger R. Bohle R-M, Kerkman L, Alhenc-Gelas F, Danilov SM. Angiotensin I-converting enzyme (CD 143) on endothelial cells in normal and in pathological conditions. In: Kishimoto T. Kikutari H, van dem Borne AEG, Goyert SM, Mason DY, Miyasaka M, et al., eds. Leucocyte typing VI: white cell differentiation antigens. New York: Garland Publishing, 1997:749-51.
5. Danilov SM, Sadovnikova E, Scharenborg N, Balysnikova IV, Svinareva DA, Semikina EL, et al. Angiotensin-converting enzyme (CD143) is abundantly ed by dendritic cells and discriminates human monocytes-derived dendritic cells from acute myeloid leukemia-derived dendritic cells. Exp Hem 2003; 31:1301-9.
6. Danilov SM, Franke FE, Erdos EG. Angiotensin-converting enzyme (CD143). In: Kishimoto T, Kikutari H, van dem Borne AEG, Goyert SM, Mason DY, Miyasaka M, et al., eds. Leucocyte typing VI: white cell differentiation antigens. New York: Garland Publishing, 1997:746-9.
7. Ching SF, Hayes LW, Slakey LL. Angiotensin-converting enzyme in cultured endothelial cells. Synthesis, degradation and transfer to culture medium. Arteriosclerosis 1983;3:581-8.
8. Hooper NM, Keen J, Pappin DJC, Turner AJ. Pig kidney angiotensin converting enzyme. Purification and characterization of amphipathic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane. Biochem J 1987;247:85-93.
9. Wei L, Alhenc-Gelas F, Corvol P, Clauser E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active, J Biol Chem 1991;266:9002-8.
10. Woodman ZL, Oppong SY, Cook S. Hooper NM, Schwager SL, Brandt WF, et al. Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites. Biochem J 2000;347:711-8.
11. Hooper NM, Karran EH, Turner AJ. Membrane protein secretases. Biochem J 1997;321:265-79.
12. Alhenc-Gelas F, Richard J, Courbon D, Warnet JM, Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med 1991;117:33-9.
13. Lieberman J. Elevation of serum angiotensin-converting enzyme level in sarcoidosis. Am J Med 1975;59:365-72.
14. Lieberman J, Beutler E. Elevation of angiotensin-converting enzyme in Gaucher's disease. N Engl J Med 1976;294:1442-4.
15. Silverstein E. Friedland J, Lyons HA, Gourin A. Elevation of angiotensin-converting enzyme in granulomatous lymph nodes and serum in sarcoidosis: clinical and possible pathological significance. Ann NY Acad Sci 1976;278: 498-513.
16. Ainslie GM. Benatar SR. Serum angiotensin converting enzyme in sarcoidosis: sensitivity and specificity in diagnosis: correlations with disease activity, duration, extra-thoracic involvement, radiographic type and therapy. Q J Med 1985;55:253-70.
17. Beneteau-Burnat B, Baudin B. Angiotensin-converting enzyme: clinical applications and laboratory investigation n serum and other biological fluids. Crit Rev Clin Lab Sci 1991;28:337-56.
18. Beutler E, Kay A, Saven A, Garver P, Thurston D, Dawson A, et al. Enzyme replacement therapy for Gaucher disease. Blood 1991;78:1183-9.
19. Kramers C, Danilov SM, Deinum J, Balyasnikova IV, Scharenborg N. Looman M, et al. Point mutation in the stalk of angiotensin-converting enzyme causes a dramatic increase in serum angiotensin-converting enzyme but no cardiovascular disease. Circulation 2001;104:1236-40.
20. Eyries M, Michaud A, Deinum J, Agrapart M, Chomilier J, Kramers C, et al. Increased shedding of angiotensin-converting enzyme by a mutation identified in the stalk region. J Biol Chem 2001;276:5525-32.
21. Okabe T, Fujisawa M, Yotsumoto H, Watanabe J, Takaku F, Lanzillo JJ, et al. Familial elevation of serum angiotensin-converting enzyme. Q J Med 1985;55:55-61.
22. Luisetti M, Martinetti M, Cuccia M, Dugoujon M, De Rose V, Peona V, et al. Familial elevation of serum angiotensin-converting enzyme activity. Eur Resp J 1990;3:441-6.
23. Kramers C, Deinum J. Increased serum activity of angiotensin-converting enzyme (ACE): indication of sarcoidosis? A Bayesian approach. Ned Tijdschr Geneeskd 2003;147:473-6.
24. Linneback M. Kesper K, Jeub M, Urbach H, Wullner U, Klockgether T, et al. Hereditary elevation of angiotensin-converting enzyme suggesting neurosar-coidosis. Neurology 2003;61:1819-20.
25. Balyasnikova IV, Metzger R, Sun Z-L, Franke FE, Berestetskaya YV, Chubb AJ, et al. Monoclonal antibodies 1B3 and 5C8 as probes for monitoring the nativity of the soluble angiotensin-converting enzyme. Hybridoma 2005;24:14-26.
26. Danilov S, Jaspard E, Churakova T, Towbin H, Savoie F, Wei L, et al. Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. J Biol Chem 1994;269:26806-14.
27. Kost OA, Balyasnikova IV, Chemodanova EE, Nikolskaya II, Albrecht RFII, Danilov SM. Epitope-dependent blocking of the angiotensin-converting enzyme dimerization by monoclonal antibodies to the N-terminal domain of ACE: possible link of ACE dimerization and shedding from the cell surface. Biochemistry 2003;42:6965-76.
28. Balyasnikova IV, Woodman ZL, Albrecht RFII, Natesh R, Acharya KR, Sturrock ED, et al. The localization of an N-domain region of angiotensin-converting enzyme involved in the regulation of ectodomain shedding using monoclonal antibodies. J Proteome Res 2005;4:258-67.
29. Daniels LB, Glew RH. β-Glucosidase assays in the diagnosis of Gaucher's disease. Clin Chem 1982;28(Pt 1):569-77.
30. Pilliquod Y, Reinharz A, Roth M. Studies on the angiotensin-converting enzyme with different substrates. Biochim Biophys Acta 1970;206:136-42.
31. Friedland J, Silverstein E. A sensitive fluorometric assay for serum angiotensin-converting enzyme. Am J Pathol 1976;66:416-24.
32. Danilov SM, Savoie F, Lenoir B, Jeunemaitre X, Azizi M, Tarnow L, et al. Development of enzyme-linked immunoassays for human angiotensin I-converting enzyme suitable for large-scale studies. J Hypertens 1996;14:719-27.